First Tracks Biotherapeutics, Inc. (TRAX)
45.11
+1.83
(+4.23%)
USD |
NASDAQ |
Aug 25, 16:00
44.89
-0.22
(-0.49%)
Pre-Market: 19:59
First Tracks Biotherapeutics Price : 45.11 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 25, 2026 | 43.27 | 46.48 | 43.27 | 45.11 | 441929.0 |
| Aug 24, 2026 | 43.47 | 44.64 | 42.56 | 43.28 | 677251.0 |
| Aug 21, 2026 | 42.98 | 44.78 | 40.72 | 43.11 | 527980.0 |
| Aug 20, 2026 | 45.50 | 45.99 | 41.78 | 41.90 | 478171.0 |
| Aug 19, 2026 | 45.25 | 46.64 | 43.84 | 45.50 | 810495.0 |
| Aug 18, 2026 | 43.76 | 45.71 | 43.10 | 43.88 | 724699.0 |
| Aug 17, 2026 | 43.85 | 44.80 | 42.74 | 43.60 | 509702.0 |
| Aug 14, 2026 | 43.46 | 45.35 | 42.41 | 44.04 | 446178.0 |
| Aug 13, 2026 | 46.15 | 46.79 | 43.00 | 44.03 | 715085.0 |
| Aug 12, 2026 | 46.54 | 48.35 | 46.00 | 46.13 | 407049.0 |
| Aug 11, 2026 | 48.94 | 49.91 | 46.47 | 46.75 | 613566.0 |
| Aug 10, 2026 | 45.71 | 48.49 | 44.90 | 47.92 | 708832.0 |
| Aug 07, 2026 | 45.93 | 46.72 | 44.82 | 45.33 | 629380.0 |
| Aug 06, 2026 | 47.25 | 47.98 | 44.95 | 45.31 | 443837.0 |
| Aug 05, 2026 | 46.99 | 47.96 | 44.67 | 46.95 | 940022.0 |
| Aug 04, 2026 | 46.21 | 49.58 | 45.74 | 46.01 | 690007.0 |
| Aug 03, 2026 | 43.49 | 47.00 | 42.05 | 46.16 | 259650.0 |
| Jul 31, 2026 | 47.70 | 47.70 | 43.53 | 44.04 | 869695.0 |
| Jul 30, 2026 | 42.78 | 48.00 | 42.50 | 47.78 | 970188.0 |
| Jul 29, 2026 | 41.11 | 43.81 | 40.60 | 41.87 | 582220.0 |
| Jul 28, 2026 | 41.31 | 42.81 | 39.81 | 41.85 | 761316.0 |
| Jul 27, 2026 | 43.37 | 46.45 | 39.60 | 42.03 | 2.592M |
| Jul 24, 2026 | 37.44 | 38.18 | 34.72 | 35.52 | 495403.0 |
| Jul 23, 2026 | 37.75 | 38.96 | 36.44 | 37.64 | 400084.0 |
| Jul 22, 2026 | 36.30 | 39.43 | 35.11 | 38.17 | 585780.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Forte Biosciences, Inc. | 76.97 |
| ACADIA Pharmaceuticals, Inc. | 30.57 |
| Agenus, Inc. | 8.36 |
| Alnylam Pharmaceuticals, Inc. | 240.08 |
| Amgen, Inc. | 442.24 |
Price Related Metrics
| Price to Book Value | 9.458 |
| Earnings Yield | -10.95% |
| Market Cap | 1.596B |